PMD Device Solutions
5.8 SEK +11.54%Be the first to follow this company
PMD Device Solutions develops and sells medical products for respiratory monitoring for both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to support the detection of patient deterioration and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is commercialised in Europe, the UK, and FDA cleared in the US.
Revenue
28.62M
EBIT %
-70.02 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
PMDS
Daily low / high price
5.7 / 6
SEK
Market cap
120.92M SEK
Turnover
8.28K SEK
Volume
1.4K
Financial calendar
Interim report
2024-08-22
Interim report
2024-11-22
Annual report
2025-02-26
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Myles Murray | 38.8 % | 38.8 % |
Anne Dorney | 9.3 % | 9.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Bulletin from the 2024 Annual General Meeting of PMD
PMD Device Solutions höjer finansiellt mål med 160% till 260 MSEK vid årsslutet 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools